Search research articles
Contact Us
Filters
Showing results (361-370 of 516) with videos related to
Page
of 52
Sort By:
Leukemia & Lymphoma
|
October 15, 2024
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma
Meletios A Dimopoulos, Magdalini Migkou, Manisha Bhutani, et al.
Leukemia
|
December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndrome
Kenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
Blood
|
February 5, 2011
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
Meletios Dimopoulos, Robert Kyle, Jean-Paul Fermand, et al.
Blood
|
August 30, 2017
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
Philippe Moreau, Asher Chanan-Khan, Andrew W Roberts, et al.
Haematologica
|
May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response
Matthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization
Ivana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Leukemia
|
September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis
Saurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.
Blood
|
October 12, 2017
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Shaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.
Page
of 52
Search research articles
Search
Showing results (361-370 of 516) with videos related to
Sort By:
Page
of 52
Leukemia & Lymphoma
|
October 15, 2024
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma
Meletios A Dimopoulos, Magdalini Migkou, Manisha Bhutani, et al.
Leukemia
|
December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndrome
Kenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
Blood
|
February 5, 2011
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
Meletios Dimopoulos, Robert Kyle, Jean-Paul Fermand, et al.
Blood
|
August 30, 2017
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
Philippe Moreau, Asher Chanan-Khan, Andrew W Roberts, et al.
Haematologica
|
May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response
Matthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization
Ivana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Leukemia
|
September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis
Saurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.
Blood
|
October 12, 2017
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Shaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.
Page
of 52